SuRo Capital Corp. (SSSS) Earnings Call Transcript & Summary

November 5, 2020

NASDAQ US Financials Capital Markets earnings 46 min

Earnings Call Speaker Segments

Adam Bates

executive
#1

Thanks for being with us on the call today. Joining me now are SuRo Capital's Chief Executive Officer, Mark Klein, along with our Chief Financial Officer, Allison Green. I want to point out that there's a slide deck matching management's prepared remarks for today, and you can find it on our site, www.surocap.com, in the Investor Relations section under Events & Presentations. This call is being recorded and streamed live at www.surocap.com. Details on how to access a replay appear in the press release we put out today; the content of this call belongs to SuRo Capital, and reproducing it in any form without authorization is strictly forbidden. I'd also like to direct your attention to the standard disclosures about forward-looking information contained in today's earnings press release. What we say during this conference call and webcast may amount to forward-looking statements, which concern future events, future performance, or financial condition; such statements don't promise anything about how we will perform or what our financial condition or results will be going forward, and they carry a variety of risks, estimates, and uncertainties, among them the effect of COVID-19 and any market volatility that might harm our business, the companies in our portfolio, our industry, and the worldwide economy, any of which could make actual results diverge materially from the plans, intentions, and expectations expressed or implied by those forward-looking statements. A range of factors could cause actual results to differ materially from what the forward-looking statements suggest, including, though not limited to, the ones we describe periodically in the company's SEC filings. Management won't commit to refreshing these forward-looking statements unless the law obliges us to. If you'd like copies of SuRo Capital's most recent SEC filings, please go to our website, www.surocap.com, or the SEC's site, sec.gov. At this point, I'll hand the call over to Mark Klein.

Mark Klein

executive
#2

Thank you, Adam. We're happy to walk you through what SuRo Capital achieved in the third quarter of 2020. Clearly, we're operating in extraordinary times, and there are enormous difficulties confronting society. Everyone here at SuRo Capital wants once more to express appreciation to the frontline workers and first responders who have placed themselves in harm's way during the COVID-19 pandemic. We feel lucky to be able to say that our team members and their loved ones are still in good health and are carrying on their work remotely. I'll talk about how our portfolio is valued amid the continuing COVID-19 pandemic and the volatility tied to the election, and I'll point out how several of our bigger holdings have actually seen some degree of business acceleration during this period of uncertainty. To wrap up, I'll turn things over to Allison Green, who will give a short financial recap. Once we've finished our comments, we'll take questions from the call. Let's begin on Slide 3. For this quarter, SuRo Capital posted its highest dividend adjusted net asset value per share going back to September of 2015. As of September 30, 2020, net asset value came in at $12.46 per share, adjusted for dividends declared during the quarter of $0.40 a share, up from $11.84 per share on June 30, 2020. Net asset value came to roughly $253 million when the quarter closed, versus $192 million in the second quarter. Kindly go to Slides 4, 5 and 6 for a look at key developments in our investment portfolio during the third quarter and after the quarter ended; we keep pursuing initiatives aimed at driving shareholder value. On October 28, the Board of Directors of SuRo Capital declared a dividend of $0.25 per share for stockholders. This dividend stemmed from year-to-date monetizations within SuRo Capital's investment portfolio and comes on top of the $0.25 per share dividend that SuRo Capital's Board of Directors declared on September 25 and paid in October. Given the activity that continues in our investment portfolio, we expect to declare one more dividend before the year is out. Also, on October 28, SuRo Capital's Board of Directors approved adding $10 million to our share repurchase program. That lifts the total sum — the dollar amount set aside for share repurchases — to $50 million, which includes the $10 million Modified Dutch Tender Offer that SuRo Capital carried out in the fourth quarter of 2019. In the third quarter, SuRo Capital completed an at the money — at-the-market offering that raised about $51 million before fees, at a weighted average price of $13.36 per share; this capital raise proved quite accretive to our NAV per share; we haven't issued any stock since September 28, which came two days ahead of the Palantir direct listing. Later on the call, Allison will share more specifics regarding the dividends, where the share repurchase program currently stands and what came of our Q3 at-the-market offering. SuRo Capital's five biggest positions as of September 30 were Coursera, Palantir, Course Hero, Nextdoor and OZY Media; those positions represented roughly 71% of the investment portfolio. By the close of business on September 30, roughly 89% of the portfolio was held in our 10 biggest positions. Now, I'd like to walk through some key things that happened with a handful of our largest holdings. Let me start by focusing on Palantir, which is our number two position. Palantir completed a direct listing on September 30 and started trading on the New York Stock Exchange. That direct listing followed Palantir's announcement that in early July it had confidentially filed a draft registration statement on Form S-1 with the SEC. Under Palantir's lock-up agreement, 20% of Palantir shares became freely tradable when the direct listing was executed. In line with how we think about monetizing our public securities, we sold some of our unrestricted shares on September 30, and the rest of the freely tradable shares went shortly after quarter end. We still hold the remaining restricted 80% of our Palantir Class A common stock, and once the lock-up period expired, we'll look at further monetization of this investment. I'd like to — and now, next, I want to point out that our online learning investments, through Coursera and Course Hero, make up 1/3 of our investment portfolio. Based on recent media coverage and earnings reports from publicly traded online learning companies, it's clear that the COVID-19 pandemic has kept driving sharp increases in demand for online education. We remain of the view that the pandemic's effects have sped up a long-term structural shift in the way education is and will be consumed, with a clear move toward online education. On July 17, Coursera, our biggest position, said it had raised $130 million in Series F financing. NEA led the round, and we took part with a $2.8 million pro rata follow-on investment. Existing investors Kleiner Perkins, Seek Group, Learn Capital and others also joined the round, which lifted the company's cash balance to over $300 million, according to the company's announcement. An online publication's report put the round's valuation of Coursera at about $2.5 billion. Per pitch book, Coursera had most recently raised $103 million in April 2019 at a $1.56 billion pre-money valuation. Coursera keeps taking steps to help students and universities through the COVID-19 pandemic. In March 2020, in response to COVID-19, Coursera started a Campus Response Initiative giving every university worldwide free access to Coursera's course catalog through Coursera for Campus. Since that launch, Coursera has activated over 10,000 programs for colleges and universities, reaching more than 1.4 million students. Coursera also started a Workforce Recovery Initiative to help governments fight unemployment. Since it began, Coursera has activated more than 220 programs for governments across 70 countries and 25 U.S. states; in June of 2020, Coursera said it was extending free access for college and university students to over 3,800 courses, 150 guided projects, 400 specializations and 11 professional certificates on the Coursera platform. Up until September 30, students had the option to sign up for the program at zero cost, and that program features online classes taught by the best universities globally plus a professional certificate from top industry educators such as Google and IBM. Given that campus shutdowns have affected 70% of learners around the world, this initiative lets them keep studying away from their classrooms. Taken together, these offerings have served over 200,000 learners. In August 2020, as a Tech Crunch piece reported, Course Hero — our third biggest holding — brought in a fresh $70 million tranche as part of its Series B funding, priced at a $1.1 billion pre-money valuation. That round lifts the overall primary capital gathered in Course Hero's Series B to $80 million. An EdSurge report said this financing drew investments from TPG, Goldman Sachs Asset Management, and other parties. That same report noted Course Hero now has more than 1 million subscribers, each paying somewhere between $10 and $40 monthly, and that Course Hero went past $100 million in revenue during the prior year. Back in February, EdSurge had reported that Course Hero collected $10 million as the first portion of its Series B round, which NewView Capital led at that $1.1 billion pre-money valuation. NewView Capital has additionally put $30 million toward the company's employee tender program.

Mark Klein

executive
#3

Because COVID-19 and the quarantines and school shutdowns that came with it meant students had less face-to-face contact with teachers or study groups, they have been leaning more and more on digital learning aids for their coursework, and that includes the online document library from Course Hero. During its October 2020 earnings call, Chegg, which is a major rival to Course Hero, pointed out that its research shows over two-thirds of U.S. undergraduates who were surveyed about what they went through during the recent lockdown. So once the pandemic is over, they would be open to more online education. On top of that, the same research discovered that around half of professors now view online as education being a teaching method that works and say they feel more ready to teach online. That marks a rise from about 35% of professors in May. Students came to Chegg in record numbers during the quarter, and expectations are that this trend will keep going all year, no matter what college campuses end up looking like. We think Course Hero is set up in a similar way to take advantage of this long-term shift toward online learning. As a reaction to the pandemic, Course Hero has given educators pre access to its document library containing over 40 million teaching and learning resources. In October of 2020, Course Hero revealed a partnership aimed at letting students hit by COVID-19 get micrograms of up to $500. Via that partnership, Course Hero's distributed funds to 1,000 students at institutions around the country. In July of this year, Course Hero also unveiled an educator exchange, in which college faculty can make income by uploading ensuring teaching, learning and study materials alongside peers and students. That exchange broadens Course Hero's push to work with faculty by offering a platform where the value of lecture notes, practice tests and teaching materials can be acknowledged and shared. Nextdoor, our fourth largest position, is a remarkable platform serving more than 219,000 neighborhoods in 11 countries. In our view, Nextdoor has enormous room to keep monetizing its hyper localized user base within the $161 billion United States local advertising market. Based on second measure, Nextdoor drew over 100 million visitors to its platform in September 2020, an increase of nearly 30% year-over-year. Since reaching local audiences through digital advertising channels has turned into one of the most significant mobile marketing trends, we believe Nextdoor has hit a critical mass of users and that it is extremely valuable to advertisers. Nextdoor's traction persisted through the COVID-19 pandemic, as the company rolled out Nextdoor groups and Nextdoor help map to give healthy individuals a chance to support neighbors in need. Broken into six general investment themes, the largest allocation in our investment portfolio is education technology, making up roughly 45% of the investment portfolio at fair value. Big data and cloud came in as the second largest category, accounting for approximately 26% of the portfolio. Our financial technology and services category made up about 11% of our portfolio at fair value. At fair value, roughly 10% of our portfolio was in the social and mobile category, while marketplaces made up about 9% of our investment portfolio. As we've mentioned before, we've widened our emphasis past our core equity strategy to include private credit and pre-SPAC merger pipes. Across all of those areas, we keep seeing a large flow of appealing opportunities. E-commerce and retail, financial technology, food technology, and transportation and logistics are a handful of the industries we're watching. So we're pleased to share that $10 million has been invested in Blink Health. On top of that, a few more investments of ours are in the last phases of closing. Kindly go to Slide 7. Blink Health operates a pharmaceutical technology platform that lets consumers obtain the medicines they require at costs they can manage. The company's mission is to disrupt the conventional pharmaceutical supply chain, giving manufacturers improved data and, even more crucially, giving consumers improved prices. Today's supply chain is needlessly complicated, and it compensates intermediaries for delivering genuine value to the final consumer. Consequently, consumers now pay more for drugs because the current supply chain depends so heavily on intermediaries. Blink's goal is to upend the current supply chain model through direct negotiations with pharmaceutical manufacturers, maintaining a steady emphasis on reducing the final cost for consumers, and simultaneously supplying essential data to the supply chain's major participants. Blink Health's B2B software platform, together with its online pharmaceutical marketplace, generates value across the supply chain by removing the requirement for conventional intermediaries in the market. The company targets the whole prescription market, creating savings on generic as well as branded drugs for cash claims and insurance-based claims alike. In light of how well GoodRx's IPO went in September, we think the public market is enthusiastic about businesses whose focus is bringing drug costs down. Although Blink faces competition from numerous participants in the pharmacy PBM and telemedicine arenas, Blink Health holds a distinctive position to prevail as it keeps applying a software and tech-enabled method to build a fresh customer experience and supply chain for prescriptions. Since Blink Health is a well-capitalized and capital efficient supplier of its pharmacy as a service platform, we see this investment as an attractive chance to take part in the disruption of today's pharmaceutical market. Last week, we completed an investment in the Series A and Series C preferred stock that we believe provides us with substantial upside in Blink Health's future. Beyond having the financial backing to keep developing its product suite, we think Blink Health's capacity to compete against large pharmacy chains, along with its value add to health systems and drug manufacturers, gives it a distinctive position to prevail. Looking forward, we believe SuRo Capital is well positioned to deliver long-term shareholder value. We are carrying out a disciplined growth investment strategy with strong tailwinds, and we believe our portfolio's fundamentals are strong. Thank you for your attention. Having said that, I'll now hand things off to Alison.

Allison Green

executive
#4

Thanks, Mark. Building on what Mark just covered, I’d like to walk through our financial results in greater depth for the period ending September 30, 2020. That includes the dividends we recently declared, how our share repurchase program has grown and where it stands, what came out of our at-the-market offering, the expense reduction push we’re still carrying out, and where our liquidity sits right now. We’re happy to share that we closed the third quarter with an NAV per share of $12.46, adjusted for $0.40 per share and dividends declared during the quarter. A breakdown of NAV per share at quarter end appears on Slide 8, and it lines up with our financial reporting. Broadly, the third quarter’s rise in NAV per share came mostly from $0.80 per share of net unrealized appreciation on our portfolio investment, roughly $0.24 per share tied to our at-the-market capital raise, and about $0.12 per share in net realized gains from exiting or selling portfolio investments. Those NAV per share gains were partly offset by $0.40 per share in dividends declared during the quarter and a $0.13 per share decline in net investment loss. Also within that, there was a $0.01 per share decrease from converting 1,780,000 — just under 5% — of our 4.75% convertible senior notes due March 2023. On July 29, our board of directors declared a dividend of $0.15 per share, paid on August 25 to shareholders of record on August 11; that dividend related to investment activity in 2019 and brings total dividends declared tied to 2019 investment activity to $0.47 per share. Every dividend attributable to 2019 has been categorized as net realized capital gains for tax purposes. On September 25, our board of directors declared a dividend of $0.25 per share, paid on October 20 to shareholders of record on October 5. That dividend relates to current year investment activity and is expected to be categorized as net realized capital gains for tax purposes. After quarter end, on October 28, our board of directors declared a dividend of $0.25 per share payable on November 30 to shareholders of record on November 10. This dividend also relates to current year investment activity and is expected to be categorized as net realized capital gains for tax purposes. As Mark noted, we expect to pay an additional dividend beyond those I just listed closer to year end. Please turn to Slide 9, where I’ll go over where the share repurchase program currently stands. During the third quarter, the company didn’t repurchase any shares because our at-the-market offering was active. As Mark said earlier, we were glad to announce that on October 28, our board of directors authorized an additional $10 million expansion of the share repurchase program; that takes the total allocation by our board of directors to the share repurchase program to $40 million. That’s on top of the $10 million, 2019 Modified Dutch Auction Tender Offer. After the quarter closed, we bought back 371,283 shares of common stock for roughly $3.1 million. Since the repurchase program began in August 2017 through today, we've repurchased 4,823,332 shares for about $30.4 million. That figure excludes the impact of the $10 million Modified Dutch Auction Tender Offer that took place in the fourth quarter of 2019. Taking into account all buybacks to date plus the board's recent additional allocation, roughly $9.6 million remains available for future purchases under the program. As of today, combining the share repurchase program with the 2019 Modified Dutch Auction Tender Offer, SuRo Capital has bought back 6,272,607 shares of common stock for approximately $40.4 million since the program started in August 2017; that's more than 28% of the shares that were outstanding at that time; on July 29, the company signed an at-the-market sales agreement with BTIG, JMP Securities and Ladenburg Thalmann to issue and sell up to $50 million in aggregate amount of shares of our common stock via an at-the-market capital raise or ATM Offering. On September 23, we raised the maximum amount of shares that could be sold through the ATM Offering to $150 million from $50 million. Our main plan is to use the net proceeds from the ATM Offering to invest in portfolio companies consistent with our investment objective and strategy. In the third quarter, we issued and sold 3,808,979 shares under the ATM Offering at a weighted average price of $13.36 per share; that produced gross proceeds of $51 million and net proceeds of $49.9 million after deducting commissions paid to the agents on the shares sold. Sales ended on September 28, before the Palantir direct listing on September 30, and no further shares have been issued or sold since September 28. As of today, up to approximately $99.1 million in aggregate amount of the shares remains available for sale under the ATM Offering, but we have no current intention of issuing additional shares of common stock under this ATM Offering at this time. In the third quarter, we kept seeing the cost saving effects from internalizing the management of SuRo Capital. As we've discussed before, as an internally managed BDC, we have a significantly reduced cost structure. When the investment advisory agreement terminated on March 12, 2019, we stopped paying management fees each month because management is now employed directly by the BDC, and we no longer accrue an incentive fee. Total operating expenses for the third quarter were approximately $3 million. That's a decrease of approximately 17% in operating expenses from $3.6 million during the third quarter of 2019, adjusted for stock based compensation expense. Compared to our last third quarter as an externally managed entity, the third quarter 2020 total operating expenses of $3 million represent a nearly 34% decrease from total operating expenses before waivers of $4.6 million in the third quarter of 2018. Turning to expenses, on an adjusted basis our total operating costs for the first nine months of 2020, or year-to-date, came to $9.2 million. That figure reflects adjustments tied to accounting guidance mandating that any unrecognized compensation costs linked to stock-based compensation be recognized on an accelerated basis whenever such stock-based compensation is cancelled without a repurchase, exchange, or replacement. This accelerated recognition, triggered by the cancellation of roughly $2 million of stock-based compensation during Q2, is offset within the equity section of the balance sheet. So the adjusted total operating expenses of $9.2 million for the first nine months of 2020 compare against $12.6 million for the same period in 2019, adjusted for the reversal of incentive fee accrual, and against $16.3 million in total operating expense prior to waivers for the first nine months of 2018. During that last year, we operated under full external management. This ongoing reduction in operating expenses stems mainly from the removal of management fees and incentive fees along with costs under the previous administration agreement, and it is further aided by continuing expense reduction initiatives beyond the savings that come inherently from the internalized management structure. We expect operating expenses to decline further in 2020, since we will be fully internalized for the whole year, and the costs tied to the internalizations were largely absorbed back in 2019. Taken together, we believe our sustained and meticulous work to bring operating expenses down, plus the meaningful cost savings we are achieving as an internally managed BDC, has continued positive impacts on NAV. We stay diligent about managing our expense base going forward. Last, I'd like to walk through SuRo Capital's current liquidity. We closed the quarter with roughly $107.3 million in liquid assets, comprising $60.3 million of cash, $7.2 million of unrestricted marketable public securities, and $39.5 million of public securities subject to lock-up restrictions. Our cash balance of $60.3 million as of September 30 consisted primarily of proceeds generated through our at the market offering and the monetization of various portfolio positions during the year. The $7.2 million of unrestricted marketable public securities and the $39.5 million of public securities subject to lockup restrictions held as of September 30 represent our shares in Palantir. In the third quarter, we sold a portion of our unrestricted Palantir shares — not included in the 7.2 million held at quarter end — for approximately $4.1 million in net proceeds, realizing roughly $3 million in gains. After quarter end, we sold our remaining unrestricted shares for approximately 7.6 million in net proceeds, realizing approximately $5.4 million in gains. That wraps up my comments. We want to thank you for your interest in and support of SuRo Capital. I'll now hand the call to the operator to begin the Q&A session, operator.

Jon Hickman

analyst
#5

Hi there, and thanks for fielding my question. I'd like to ask about the funding rounds you mentioned — Coursera came in at $2.5 billion, and Course Hero at $1.1 billion, if I have that right. Can you share where those stakes stand in your books as of September 30?

Mark Klein

executive
#6

Hey, Jon. Appreciate you calling in, and thanks for sticking with us. As you're aware, we stay quiet about company valuations themselves — we speak only to what our positions are worth, and how they perform, rather than anything tied to overall corporate worth. That said, when it comes to how we assess things, you know we rely on a range of inputs, including the most recent funding round; on top of that we factor in things like secondary market activity and the waterfall along with the capital structure. So I realize this isn't a direct answer to what you asked, but generally speaking, what we assign tends to land somewhat below — or perhaps a bit more than somewhat below — the most recent round that was priced, though usually it's beneath that level.

Jon Hickman

analyst
#7

Right. Didn’t you apply something like a private discount to that the previous time?

Mark Klein

executive
#8

In our evaluation work, there’s a set of steps we take, and I know you and I have gone over this at length. What we do is use our heuristics in those evaluations, and those cover, though they aren’t restricted to, the most recent round of trading in the secondary markets; when those variables aren’t available, we turn to public comps.

Jon Hickman

analyst
#9

All right. And then, I believe I came across something not long ago indicating that Nextdoor was looking at going public. Is there anything on that topic you can share that’s out there already?

Mark Klein

executive
#10

Well, Jon, roughly 14 days back, a Bloomberg piece appeared, written by that outlet’s SPAC correspondent, in which she said she thought Nextdoor had been holding talks with one or multiple SPACs, with the company valued somewhere from $4 billion to $5 billion. That’s the information we saw. It’s likely the same thing you saw, and it’s the extent of what we have or are able to address.

Jon Hickman

analyst
#11

All right. And I apologize, one final item from me. Regarding the Blink business model, they generate revenue by working straight with the manufacturer, and as a result, they capture a margin sitting between that party and the consumer. Is that the way it operates?

Mark Klein

executive
#12

Correct. Their main value offer, though, centers on you, the consumer, when your physician recommends choosing a particular medication, and upon being asked which pharmacy you use, you name Blink, after which they get loaded into the Blink system. From there, you're able to select whichever pharmacy you like and obtain pricing at that pharmacy, whether you'd prefer delivery or pickup; and a genuine benefit they deliver stems from their relationships with both generic versions and the branded equivalents; the pricing they secure is identical, proper, and the most favorable available at any given pharmacy, rather than forcing you to scramble around, visiting Walgreens for this and maybe your neighborhood pharmacy for that.

Andrew Harte

analyst
#13

Hey there, good evening. Great. How's it going? Thanks. I was hoping you might be able to provide some sort of update regarding how the pipeline is shaping up, plus upcoming credit investments. Then, to follow up on that, perhaps you could tell us when we might anticipate seeing some investments down the road, in the — in any SPAC acquisitions, premerger SPAC acquisitions.

Mark Klein

executive
#14

Well, clearly, we've just — we sort of disclosed, and we always disclose this in our prepared remarks. During this quarter, we have looked at close to 60 separate portfolio companies, with a good number of those being credit opportunities. The credit work is extensive, having it there, it's bespoke. So we're putting together term sheets for that, which takes far longer than an equity being offered at a price or a negotiation along those lines; we have a number of credit investments at various stages of being finished. We have term sheets out with a few of them, and we have more advanced dialogues with some of them. That being said, on the SPAC pipe side, we are extremely active in examining those, clearly, there's been a huge amount of activity in the SPAC from both the underwriting, as well as the announcement of SPAC transactions; we've gone down that road on quite, I'd say one, several we've gotten very deep down that road on a couple; and we may be in a position to announce that we've wrapped up one or two as we close out calendar year.

Ron Levine

analyst
#15

Hi, this is Ron Levine. Mark, I'd like to ask about Coursera. Do you have anything to say regarding how profitable it is right now, or any idea the company might have about an IPO?

Mark Klein

executive
#16

Thank you, Ron, and I appreciate the question. Clearly, a good deal has appeared publicly concerning Coursera, considering its scale and the point it has reached in terms of market saturation; and pieces have been published discussing the possibility that it could or could not become publicly traded. As far as any remarks we make, we're only speaking about information that's already publicly available. And what everyone can see out there has led investors to think that this company is considering a move toward going public. When exactly that might happen is still not clear.

Ron Levine

analyst
#17

All right. For my second question, do you have any sense of why the shares trade so far below net asset value, particularly given all the adjustments this current management group has implemented, which I genuinely value a great deal and want to offer my congratulations on.

Mark Klein

executive
#18

Thank you, Ron. Well, let me offer a few thoughts, I suppose. The swings we have seen in our share price across the past six months — or if you actually want to trace things back to when COVID first hit — have been unlike anything our stock has ever gone through. Naturally, once Palantir became a public company, and with all the attention Palantir received and the enthusiasm surrounding it, interest in our firm broadened considerably as investors learned via assorted publications, articles and analysts that this represented a sizable holding within our portfolio; and our stock was driven up steeply. And I believe when Palantir went public, the valuation stood at roughly $22 billion, clearly well above the peak valuation we had carried and on an absolute basis, something we found quite thrilling. I think the investing public saw it as somewhat underwhelming. So then that same wave of people who had rushed in and pushed the stock higher turned into sellers of our shares. So we ended up with a sort of pendulum dynamic in terms of what transpired, and our stock was unloaded rather indiscriminately, in my view, and ideally today serves as a sign, and the stock, and even across the past few days, that the selling has completely faded. I believe there has been something of a rotation in who our shareholders are. From speaking with many of our shareholders, I genuinely believe that those who are now purchasing our stock or holding our stock understand that this is quite an appealing vehicle and that our net asset value is very sensible. And that our portfolio extended well beyond being a one-trick pony tied to Palantir; and the reality is we continue to hold 80% of our Palantir and possess a substantial amount of value sitting there that will be generated. But I think investors are starting to grasp the worth of what we talk about, even regarding three of our top five — four of our top five holdings, not to mention certain other positions we have. So I think the discount right now is far more a result of the volatility in the stock. I think the steps we keep taking and we seized the opportunity, correct. The notion of the stock falling to the low $8 range when their NAV stood at $12.46 represented a terrific chance for our Board to extend our — and enlarge our buyback; so since if we are able to repurchase stock, which is at — the stock must climb 50% to return to our NAV, that amounts to trading at a 37% discount. Thus this presented a chance for us to generate value for shareholders through keeping the share count at that particular level. Yet I do not — I truly do not think you will keep witnessing major discounts, since our portfolio keeps containing businesses that now are genuinely showing how strong they are. Monetizations are going to happen inside our portfolio. We are getting chances to make investments such as the one we recently completed in Blink, along with some other developments taking place. So I simply believe it is — we are not the same old GSV, so to speak. And along those lines, I believe you witnessed our stock trading above NAV for the very first time. And definitely at a 10% and 15% premiums to NAV, that was the first instance in roughly eight years where that took place. That comes from many of the actions we are taking. And I expect the stock will begin trading back up to around or near NAV, now that the shareholder base is somewhat disappointed and the volatility is fading from it somewhat.

Analyst

analyst
#19

Hello, and thanks for letting me join. I'm simply wondering whether this company has at any point thought about forming a vehicle of its own, perhaps to bring some of those smaller stakes into the public markets, should they want that, or whether that's a thing that could even be done.

Mark Klein

executive
#20

Building stacks for our own account isn't what we do. In my view, plenty of really strong sponsors exist in the market. In my view, our chance to put money into pipes that those sponsors structure for the transactions they're putting together fits a pre-IPO approach that we find quite compelling. At some moment, I believe we'll get the chance to take part on what I've described as the Founder's equity side. That's assuming we decided to commit risk capital alongside specs, yet forming pipes — forming specs — falls outside our mandate. That isn't something we'll do. Alongside other sponsors, we will take part, whether in two pipes or perhaps eventually in their Founder's equity too.

Mark Klein

executive
#21

I appreciate everyone making the effort to join, and it's clearly a very fascinating moment nationwide, what with the election and the pandemic happening together. We're truly grateful for the time you're giving us, as well as the backing so many of you have shown toward us and the leadership team directly. So thanks a lot to each of you, and do your best to remain well. Thanks, goodbye.

Operator

operator
#22

That brings us to the end of this call. Once more, we appreciate everyone for joining, and you're free to hang up at this point.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete SuRo Capital Corp. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to SuRo Capital Corp. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in SuRo Capital Corp. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.